Global Nasal Packing Devices Market Size study, By Product (Injectable, Gel, Spray, Dressings), By Type (Bioresorbable, Non-absorbable), and Regional Forecasts 2022-2028

Global Nasal Packing Devices Market Size study, By Product (Injectable, Gel, Spray, Dressings), By Type (Bioresorbable, Non-absorbable), and Regional Forecasts 2022-2028

Global Nasal Packing Devices Market is valued at approximately USDXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Nasal packing devices are intranasal devices, which are used to apply constant local pressure to the nasal septum. This is adopted to treat epistaxis (nosebleed), it is a condition in which a small blood vessel ruptures in the nose lining. The growing incidences of epistaxis, an increasing number of technological developments, coupled with the rising medical expenditure are the several key factors soaring the global market demand across the forecast period. For instance, as per the Centers for Medicare and Medicaid Service, in the US healthcare spending was recorded at USD 4.1 trillion in 2020. Also, this national health spending is anticipated to increase at an average annual rate of 5.4 percent for 2019-28 and is likely to reach USD 6.2 trillion by 2028. Therefore, the increasing healthcare expenditure is bolstering the global market growth in the near future. However, infectious complications and toxic shock syndrome (TSS) may curb the growth of the market over the forecast period of 2022-2028. Also, a rise in the number of product launches and increasing investment in R&D activities are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Nasal Packing Devices Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing technological developments in the healthcare industry and the rising presence of the various nasal packing device manufacturers. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing number of epistaxis patients, as well as, rising healthcare spending, would create lucrative growth prospects for the Nasal Packing Devices Market across the Asia-Pacific region.

Major market players included in this report are:
Summit Health
Smith & Nephew
Stryker Corporation
Medtronic plc.
Network medical products ltd.
Olympus
Lohmann & Rauscher
Meril Life Sciences Pvt Ltd.
FABCO
Aegis Lifesciences

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Injectable
Gel
Spray
Dressings
By Type:
Bioresorbable
Non-absorbable
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Nasal Packing Devices Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


Companies Mentioned

Summit Health
Smith & Nephew
Stryker Corporation
Medtronic plc.
Network medical products ltd.
Olympus
Lohmann & Rauscher
Meril Life Sciences Pvt Ltd.
FABCO
Aegis Lifesciences

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.